Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

To escape radiation, tumor cells reversibly damage their DNA

April 29, 2022

Idorsia Pharmaceuticals patents LGALS3 inhibitors

April 29, 2022

Dana-Farber Cancer Institute discloses new HER2 inhibitors

April 29, 2022

AT-0174 IDO/TDO dual inhibitor shows promise for treating platinum-resistant NSCLC

April 28, 2022

Medy-Tox patents new BTK inhibitors

April 28, 2022

University of Texas System identifies CBP and/or p300 inhibitors

April 28, 2022

New YAP1/TEAD interaction inhibitors disclosed by SpringWorks Therapeutics and collaborators

April 28, 2022

Chinese researchers divulge new compounds for cancer

April 28, 2022

BLU-222 shows efficacy in CCNE1-amplified ovarian cancer models

April 28, 2022

KSHN-001034, a novel prodrug that delivers higher fulvestrant concentrations

April 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...